All The World's News
Recent News Headlines : Joyjeet Das -
CVS-AETNA DEAL TO CHANGE HOW BIG EMPLOYERS BUY HEALTH BENEFITS
In scale, CVS and Aetna offer a much bigger pharmacy benefits manager than UnitedHealth, which expanded its OptumRx business with the 13 billion purchase of Catamaran in 2015... READ MORE›
NEW, LONG-ACTING DRUGS CUT FREQUENCY OF MIGRAINE HEADACHES
NEW YORK - New, long-acting drugs may hold hope for millions of people who often suffer migraines... READ MORE›
THIS SIMPLE LIQUID IS SUDDENLY IN SHORT SUPPLY
Pfizer says it's coordinating with ICU Medical to produce records for the Justice Department... READ MORE›
U.S. APPROVES DIGITAL PILL THAT TRACKS WHEN PATIENTS TAKE IT
U.S. regulators have approved the first digital pill with an embedded sensor to track if patients are taking their medication properly, marking a significa... READ MORE›
CVS DEAL FOR AETNA COULD HELP RETAILER FACE AMAZON ENTRY
Shares of Aetna, the third-largest U.S. health insurer, closed down 3 percent on Friday after closing 12 percent higher on Thursday on reports of the deal... READ MORE›
NATIONWIDE DRUG, MEDICAL-DEVICE SHORTAGES FEARED AS PUERTO RICO STRUGGLES TO RECOVER
Pharmaceuticals and medical devices are the island's leading exports, and Puerto Rico has become one of the world's biggest centers for pharmaceutical manufacturing... READ MORE›
Trending News Headlines : Joyjeet Das
SHOPPERS DRUG MART FORMALLY APPLIES TO DISTRIBUTE MEDICAL MARIJUANA
Shoppers Drug Mart wants in on dispensing medical marijuana... READ MORE›
TRUMP POISED TO NOMINATE SCOTT GOTTLIEB TO HEAD FDA
Between 2005 and 2007 Gottlieb was FDA deputy commissioner for medical and scientific affairs... READ MORE›
CVS HEALTH IS SUED OVER 'CLAWBACKS' OF PRESCRIPTION DRUG CO-PAYS
And CVS Caremark, according to the suit filed Monday in federal court in Rhode Island... READ MORE›
DRUG COSTS TOO HIGH FIRE THE MIDDLEMAN
Pharmacy benefit managers process prescriptions for insurers and negotiate with manufacturers on one end and pharmacies on the other... READ MORE›
'HIGH RISK OF BIAS': DOCTOR RAISES DOUBTS OVER STUDY INTO MORNING-SICKNESS DRUG
For women with high risk of nausea and vomiting in pregnancy, the society recommends vitamin B6 or Diclectin... READ MORE›
BEIJING BUYERS CLUB? CHINA'S CANCER PATIENTS GAMBLE ON GRAY MARKET
The overall 5-year survival rate for cancer in China is just over 30 percent, less than half the level in the United States, according to Deutsche Bank... READ MORE›
TRUMP SINKS PHARMA STOCKS ON MEDICARE DRUG PRICE NEGOTIATION
The Standard Poor's 500 Health Care Sector Index was little changed... READ MORE›
DIY DIAGNOSIS OF ILLNESS IS DANGEROUS TREND, SAY PHARMACISTS
The Medicines and Healthcare Products Regulatory Agency advises patients never to share with others drugs they have been prescribed... READ MORE›
RAT POISON LINKED TO INDIA STERILISATION DEATHS, WITH DEATH TOLL EXPECTED TO RISE
Rat poison linked to india sterilisation deaths with death toll expected to rise... READ MORE›
EXCLUSIVE: U.S. CARDINAL HEALTH PUTS $1.5 BILLION CHINA BUSINESS ON BLOCK - SOURCES
Cardinal wants to exit over worries China's upcoming drug distribution reform could slow its growth, according to the first source... READ MORE›
DESPITE LAWSUITS OVER DRUG PRICES, INSURANCE GIANT TOUTS REVENUE GROWTH, CLAIMS TO HAVE LOWERED DRUG COSTS
"Revenue yield per script [prescription] was flat as we effectively passed supply chain improvements on to our customers... READ MORE›
UNITEDHEALTH TO BUY PHARMACY BENEFIT FIRM CATAMARAN FOR $12.8 BILLION
UnitedHealth to buy pharmacy benefit firm Catamaran for 12.8 billion... READ MORE›
INSIDE THE FIGHT TO END DRUG PRICE-GOUGING
Read Democratic Power Players Help Pharmaceutical Industry In Connecticut Battle Senators in Connecticut, where insurer Cigna Corp... READ MORE›
'PHARMA BRO' MARTIN SHKRELI FRAUD TRIAL OPENS IN NEW YORK
Former pharmaceutical chief executive Martin Shkreli has gone on trial in New York charged with fraud... READ MORE›
NEW HEALTHCARE LAW IS A WIN FOR LOBBYISTS AND DRUG COMPANIES
Some, but not all of Bosarge's requests were integrated into the final version of the 21st Century Cures Act... READ MORE›
BIOTECH BUYS GET PHARMA M&A OFF TO FLYING START IN 2015
AbbVie's planned purchase of Pharmacyclics is the largest global pharmaceutical deal of 2015 to date and takes M A activity in the sector to a six-year high... READ MORE›
J M SMUCKER TO BUY MEOW MIX OWNER IN PET FOOD PUSH
Ly 1zQGY3G By acquiring San Francisco-based Big Heart, Smucker gains ownership of the 9Lives cat food brand and Kibbles 'n Bits dog food... READ MORE›
INFAMOUS 'PHARMA BRO' MARTIN SHKRELI CHARGED WITH FRAUD IN NEW YORK
Martin Shkreli, 32, allegedly defrauded investors in two hedge funds he founded and in Retrophin, a pharmaceutical firm he previously led... READ MORE›
GENERIC DRUGS PUSH CONCERNING FOR ETHNIC COMMUNITIES
Doctors are concerned a rumoured government plan to have patients prescribed cheaper generic drugs over brand names could pose health risks for ethnically-diverse communities... READ MORE›
ASTRAZENECA SELLS U.S. GOUT DRUG RIGHTS TO IRONWOOD FOR UP TO $265 MILLION
Ironwood will also pay AstraZeneca tiered single-digit royalties on product sales... READ MORE›
THE WORLD'S FIRST FEMALE SEX DRUG, SET FOR U.S. RELEASE, COULD SPUR SIMILAR MEDICATIONS
Where Viagra and other men's erectile dysfunction drugs work by increasing blood flow to the genitals, Addyi acts on brain chemicals associated with desire... READ MORE›
RITE AID ENTERS PHARMACY BENEFIT BUSINESS WITH ENVISIONRX BUY
Pharmacy benefit managers have been striking deals with drugmakers to get discounts by offering exclusive distribution... READ MORE›
SOUTH AFRICA'S ASPEN PHARMACARE SIGNS U.S. SUPPLY DEAL WITH ANI
Aspen will supply the treatment in finished dose form to ANI, who will then market and distribute it in the United States... READ MORE›
PATIENT DIES AFTER TAKING PART IN BOTCHED FRENCH DRUG TRIAL
The drug is aimed at easing pain and mood and anxiety troubles, as well as motor problems linked to neurodegenerative illnesses... READ MORE›
WORLD'S 'MOST HATED MAN' MARTIN SHKRELI FACES CRITICS OVER DRUG PRICE RISE
Asked to identify the biggest problem with the pharmaceutical industry, Mr Shkreli suggested it was a decline in research and development... READ MORE›
HOUSE COMMITTEE SUBPOENAS SHKRELI ON DRUG PRICES
Embattled pharmaceutical businessman Martin Shkreli has been subpoenaed to testify at an upcoming congressional hearing on prescription drug market developments... READ MORE›
RESEARCHERS LOOK TO REPURPOSE APPROVED DRUGS TO TREAT ZIKA VIRUS
Doctors hope that drugs approved for other diseases might also work against the Zika virus... READ MORE›
WORLD'S 'MOST HATED MAN' MARTIN SHKRELI FACES CRITICS OVER DRUG PRICE RISE
Mr Shkreli hit the headlines last month when his biotech firm Turing Pharmaceuticals announced it would increase the price of Daraprim from US18 25 to US750... READ MORE›
MARTIN SHKRELI DEBUTS SECRET WU-TANG ALBUM AFTER TRUMP WIN
Shkreli promised last month to release Once Upon a Time in Shaolin if the Republican took the White House... READ MORE›
FTC APPROVES ENDO'S PURCHASE OF PAR PHARMACEUTICALS WITH TWO DIVESTMENTS
Antitrust approval to buy Par Pharmaceuticals Inc on condition that it divest two generic medicines the Federal Trade Commission said on Friday... READ MORE›